Skip to content

comparison of analgesic effect of Expressed breast milk (EBM) versus formula and dextrose 50%during venipuncture

comparison of analgesic effect of Expressed breast milk (EBM) versus formula and dextrose 50%during venipuncture

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138808122658N1
Enrollment
30
Registered
2011-04-06
Start date
2009-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain. Pain, not elsewhere classified

Interventions

Intervention 1: using of Expressed breast milk 2 cc, one dose , daily. Intervention 2: dextrose 50% , one dose , daily. Intervention 3: formula , one dose , daily.
Prevention
using of Expressed breast milk 2 cc, one dose , daily
dextrose 50% , one dose , daily
formula , one dose , daily

Sponsors

Lorestan University of Medical Sciences Vice Chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: the study population included full term healthy neonate, up to 14 days of post natal age who admitted because of physiologic icter . Exclusion criteria: where babies with any medical or congenital conditions such as non pathological icter , sepsis, asphyxia , major congenital malformations ,....

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: daily during venipuncture. Method of measurement: DAN score.

Secondary

MeasureTime frame
Long term effects of painful exprience such as hypersensitivity to painful stimuli. Timepoint: daily during venipuncture. Method of measurement: DAN score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Tarhani MD

Lorestan University of Medical Sciences

f_tarhani44@yahoo.com+98 66 1421 9124

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026